Covered recipient · General Payments record
LISA GRUNEBAUM
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2024
$106,461.19
- Reported across 163 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,743.68 | 15 |
| Consulting Fee | $1,150.00 | 1 |
| Travel and Lodging | $963.94 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $3,268.18 | 15 |
| Galderma Laboratories, L.P. | $589.44 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $81.99 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845186 | CMS |
| ABBVIE INC. | $175.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845188 | CMS |
| ABBVIE INC. | $116.51 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845190 | CMS |
| ABBVIE INC. | $124.99 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845192 | CMS |
| ABBVIE INC. | $1,150.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103135089 | CMS |
| ABBVIE INC. | $141.17 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845194 | CMS |
| ABBVIE INC. | $183.00 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104187480 | CMS |
| ABBVIE INC. | $366.43 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104187482 | CMS |
| ABBVIE INC. | $24.55 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845196 | CMS |
| ABBVIE INC. | $24.55 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845198 | CMS |
| ABBVIE INC. | $61.65 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845200 | CMS |
| ABBVIE INC. | $69.56 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845202 | CMS |
| ABBVIE INC. | $414.51 | 05/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104187484 | CMS |
| ABBVIE INC. | $205.80 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845204 | CMS |
| ABBVIE INC. | $128.47 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845206 | CMS |
| Galderma Laboratories, L.P. | $160.04 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145301723 | CMS |
| Galderma Laboratories, L.P. | $149.33 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145301725 | CMS |
| Galderma Laboratories, L.P. | $147.05 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145301727 | CMS |
| Galderma Laboratories, L.P. | $133.02 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145301729 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.